Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec 4;2020(1):606-611.
doi: 10.1182/hematology.2020000147.

Role of venous stenting for venous thromboembolism

Karen Breen  1
Affiliations
Review

Role of venous stenting for venous thromboembolism

Karen Breen. Hematology Am Soc Hematol Educ Program. .

Abstract

Endovenous stenting has emerged as the method of choice to treat iliofemoral venous outflow obstruction. It is used in patients with established postthrombotic syndrome (PTS) after previous deep vein thrombosis (DVT) to reduce symptoms of chronic pain and swelling and to aid ulcer healing in severe cases. Venous stenting is used to alleviate symptoms of obstruction in patients presenting with acute DVT, with the aim of preventing development of PTS. There is a low risk of morbidity and mortality associated with the use of endovenous stenting, and although significant advances have been made, particularly improvements in stent design for use in the venous circulation, data are lacking on beneficial long-term outcomes. Unmet research needs include optimal patient selection, anticoagulant choice and duration, best practice for postoperative surveillance, and use of validated assessment tools to measure outcomes. In this article, I address the potential benefits, as well as the challenges, of endovenous stenting.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: K.B. has received speaker fees from Boston Scientific and Bayer.

Figures

None
Graphical abstract
Figure 1.
Figure 1.
The Vici venous stent system.
Figure 2.
Figure 2.
Example of thrombosed iliofemoral lesion with collateralization before venous stenting.
Figure 3.
Figure 3.
Improved vascular flow after venous stenting using the Abre stent (Medtronic).
See this image and copyright information in PMC

References

    1. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ III. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998;158(6):585-593. - PubMed
    1. Kahn SR, Solymoss S, Lamping DL, Abenhaim L. Long-term outcomes after deep vein thrombosis: postphlebitic syndrome and quality of life. J Gen Intern Med. 2000;15(6):425-429. - PMC - PubMed
    1. Villalta S, Bagatella P, Piccioli A, et al. . Assessment of validity and reproducibility of a clinical scale for the post-thrombotic syndrome. Haemostasis. 1994;24.
    1. Porter JM, Moneta GL; International Consensus Committee on Chronic Venous Disease. Reporting standards in venous disease: an update. J Vasc Surg. 1995;21(4):635-645. - PubMed
    1. Rutherford RB, Padberg FT Jr, Comerota AJ, Kistner RL, Meissner MH, Moneta GL. Venous severity scoring: an adjunct to venous outcome assessment. J Vasc Surg. 2000;31(6):1307-1312. - PubMed